Distribution Manufacturing Events Testing Growers Government Celebrity Dispensary Edible Banking

Neptune announces binding agreement for divestiture of cannabis assets
by Staff Writers
Laval, Canada (TDN) Oct 31, 2022


Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a diversified and fully integrated health and wellness company, has entered into a binding agreement to divest its cannabis business which includes the cannabis plant in Sherbrooke, Quebec, the Mood Ring and PanHash brands, and related assets (the "Transaction").

The Company has reached an agreement with PurCann Pharma Inc. ("PurCann Pharma"), a subsidiary of Groupe SiliCycle, a Quebec based company with over 27 years of experience with extracting and purifying active ingredients from natural biomass, to purchase Neptune's cannabis assets for C$5.15 million to be paid in cash.

Neptune intends to use the net proceeds from the sale of these assets to for working capital and other general corporate purposes.

As part of the Transaction, the Company has received an opinion from its financial advisor, Stifel GMP, that the consideration to be received by the Company as part of the Transaction is fair, from a financial point of view. The Transaction is expected to close on or before November 15, 2022, upon completion of standard closing requirements.

Ray Silcock, Chief Financial Officer of Neptune, said, "The complete divestiture of our cannabis business is a critical milestone in executing upon our strategy to become a leading CPG company. We are nearing an inflection point with our flagship brand Sprout Organics and expect it to serve as the key growth driver for Neptune going forward. In addition, the divestment of the cannabis assets will allow us to realize significant cost savings and operational streamlining from redirected resources towards our simplified corporate structure."

PurCann Pharma is already present in the Canadian cannabis market with its therapeutic brand OOVIE and its recreational cannabis brand OLLOPA. Hugo St-Laurent president of PurCann Pharma is delighted: "With this transaction, PurCann Pharma consolidates its position in the cannabis market and is also aligned with our mission to provide pharmaceutical grade ingredients and cannabinoids to the life science market."

Neptune has retained Stifel GMP as its sole financial advisor and Osler, Hoskin and Harcourt LLP as legal counsel in connection with the Transaction.

Related Links
Neptune Wellness Solutions

Frontier Risk Group to develop first tech-enabled insurance solution for the cannabis sector
Westport CT (TDN) Oct 21, 2022
Frontier Risk Group has announced its launch, formally bringing together a team of seasoned executives and experts from the insurance and cannabis industries to build the first tech-enabled insurance ecosystem to better service cannabis risk. The former CEO of Parallel, Inc. and cannabis industry pioneer James Whitcomb, teamed up with IA Capital Group, the leading insurtech-focused investment firm to form the Company. In addition to announcing the appointment of James Whitcomb as its CEO, Frontier ... read more

Pick Your Cannabis Dispensary

New Mexico
North Dakota
Rhode Island

The content herein, unless otherwise known to be public domain, are Copyright 2020-2022 - THE DAILY NETWORK LLC. Additional copyrights may apply in whole or part to other bona fide parties. All websites are published in United States of America and are solely subject to US law and governed by Fair Use principals for news reporting and research purposes. No Content or Advertising herein implies endorsement, agreement or approval of any opinions, statements or information provided by THE DAILY NETWORK LLC on any Web page published or hosted by THE DAILY NETWORK LLC. Questions? Email Editor@IndicaDaily.com Privacy Statement